Avalon Capital Management’s Eli Lilly LLY Stock Holding History

Avalon Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.4M	Buy	13,646 +6,065	+80%	+$6.2M	3.87%	7
2026 Q1	$6.97M	Sell	7,581 -6,642	-47%	-$6.73M	1.97%	16
2025 Q4	$15.3M	Buy	14,223 +9,004	+173%	+$8.61M	3.66%	6
2025 Q3	$3.98M	Hold	5,219	–	–	0.98%	27
2025 Q2	$4.07M	Sell	5,219 -340	-6%	-$264K	1.09%	28
2025 Q1	$4.59M	Buy	5,559 +347	+7%	+$289K	1.33%	25
2024 Q4	$4.02M	Hold	5,212	–	–	1.3%	19
2024 Q3	$4.62M	Sell	5,212 -400	-7%	-$360K	1.4%	22
2024 Q2	$5.08M	Buy	5,612 +12	+0.2%	+$9.6K	1.61%	17
2024 Q1	$4.36M	Hold	5,600	–	–	1.79%	16
2023 Q4	$3.26M	Hold	5,600	–	–	1.37%	22
2023 Q3	$3.01M	Hold	5,600	–	–	1.53%	21
2023 Q2	$2.63M	Hold	5,600	–	–	1.23%	23
2023 Q1	$1.92M	Sell	5,600 -129	-2%	-$43.5K	0.99%	22
2022 Q4	$2.1M	Buy	5,729 +329	+6%	+$117K	1.06%	18
2022 Q3	$1.75M	Hold	5,400	–	–	0.84%	23
2022 Q2	$1.75M	Hold	5,400	–	–	0.72%	23
2022 Q1	$1.58M	Buy	+5,400	New	+$1.39M	0.61%	27

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avalon Capital Management's LLY Position: Q2 2026 in Review

Avalon Capital Management increased its Eli Lilly (LLY) stake by 80% in Q2 2026, buying an estimated $6.2M and bringing the position to 13,646 shares worth $16.4M. The position accounts for 3.87% of the portfolio, ranked #7.

Avalon Capital Management first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Avalon Capital Management held 13,646 shares of Eli Lilly worth $16.4M as of Q2 2026.
Avalon Capital Management bought 6,065 Eli Lilly shares in Q2 2026, an estimated $6.2M.
Eli Lilly made up 3.87% of Avalon Capital Management's portfolio in Q2 2026, its #7 holding.
Avalon Capital Management first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Avalon Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.